You searched for Neurosciences

- 30 Janvier 2026

Ipsen expands pre-clinical pipeline in rare neurodegenerative diseases

PARIS, FRANCE 30 January 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today a new global collaboration and option agreement with Origami Therapeutics for a research stage protein degrader program targeting genetic neurodegenerative diseases. Followin...

- 30 Janvier 2026

Ipsen élargit son portefeuille de produits en phase préclinique dans le domaine des maladies neurodégénératives rares

PARIS, FRANCE 30 janvier 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) annonce aujourd'hui un nouvel accord de collaboration mondiale et d'option avec Origami Therapeutics pour un programme de recherche sur les dégradeurs de protéines ciblant les maladies neu...

- 09 Janvier 2026

Ipsen Statement on Lanreotide Generic Supply Challenges

Attachment...

- 03 Juillet 2025

Ipsen inaugure son nouveau siège social mondial à Paris, en présence du Ministre de la Santé et de l’Accès aux soins Yannick Neuder

...

- 05 Décembre 2025

Ipsen provides update on legacy of Henri Beaufour

PARIS, FRANCE, 5 December 2025, Ipsen (Euronext: IPN; ADR: IPSEY) has been informed that the shares of Beech Tree will be transferred to the Alasol Foundation, in accordance with the wishes of Mr. Henri Beaufour, Ipsen’s Board Member and a representativ...

- 27 Août 2024

Ipsen announces sale of Priority Review Voucher for $158m

PARIS, FRANCE, 27 August 2024 - Ipsen (Euronext: IPN; ADR: IPSEY) has entered into an agreement to sell its rare pediatric disease Priority Review Voucher (PRV) to a large global pharmaceutical company. Ipsen received the PRV coinciding with the SohonosTM ...

- 23 Mars 2026

Ipsen provides clarifications regarding the succession of Mr. Henri Beaufour – Group governance agreement relating to Beech Tree*

PARIS, FRANCE, 23 March 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) has been informed that Beech Tree, which holds directly and indirectly 26.03% of the share capital and 33.05% of the voting rights of Ipsen SA, announces that Altawin, Fondation Alasol and B...

- 14 Octobre 2025

Ipsen announces the conclusion of an agreement between its main shareholders representing 52.06% of the capital and 66.15% of the voting rights

PARIS, FRANCE, 14 OCTOBER 2025 - Ipsen (Euronext: IPN: ADR: IPSEY) announced today that its Board of Directors has been informed of the conclusion of a new agreement1 between Highrock (controlled by Anne Beaufour), Beech Tree (controlled by Henri Beaufour)...

- 13 Mars 2025

Ipsen announces assigned Investment Grade ratings from S&P Global Ratings and Moody’s

PARIS, FRANCE, March 13th, 2025 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty care-driven company, announced today it has been assigned long-term credit ratings of Baa3 by Moody’s and BBB- by S&P Global Ratings, both with a “Stable” out...